GlassScriptPhysician profile
Gabriel Yuil
NPI 1639100886
$2,547.98
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,396 · 2020: $822 · 2021: $331.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $471.15 | 2019-2021 | |
| Novo Nordisk INC | $403.79 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $234.16 | 2019-2021 | |
| Allergan, INC. | $209.99 | 2019-2020 | |
| Lilly USA, LLC | $191.98 | 2019-2021 | |
| Glaxosmithkline, LLC. | $155.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $155.87 | 2019-2021 | |
| Pfizer INC. | $143.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $140.93 | 2019-2021 | |
| Ironwood Pharmaceuticals, INC | $76.59 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $75.38 | 2019-2021 | |
| Abbvie INC. | $53.62 | 2020-2021 | |
| Amgen INC. | $53.09 | 2020 | |
| Gilead Sciences, INC. | $45.65 | 2019-2021 | |
| Amarin Pharma, INC. | $43.30 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $35.73 | 2020 | |
| Genentech USA, INC. | $16.54 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.57 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.11 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabriel Yuil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.